Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Serpick

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer|December 1, 1970
Leukemic infiltration of the prostate: a reversible form of urinary obstructionW E Mitch, A A Serpick
Cancer Research|August 1, 1970
Prolonged intravenous methotrexate therapy in the treatment of acute leukemia and solid tumorsJ A Gottlieb, A A Serpick
Oncology|January 1, 1971
Clinical evaluation of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in malignant melanoma and other neoplasms: comparison of twice-weekly and daily administration schedulesJ A Gottlieb, A A Serpick
Blood|March 1, 1970
Granulocytic sarcoma (chloroma)P H Wiernik, A A Serpick
Cancer Chemotherapy Reports|October 1, 1970
An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lungJ A Gottlieb, A A Serpick
Cancer|March 1, 1970
Effect of large intermittent intravenous doses of cyclophosphamide in lymphomaD Mendelson, J B Block, A A Serpick
Cancer|May 1, 1970
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcomaS Lowenbraun, V T DeVita, A A Serpick
The American Journal of Medicine|January 1, 1971
Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapyS Lowenbraun, H E Ramsey, A A Serpick
Blood|December 1, 1970
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's diseaseS Lowenbraun, V T DeVita, A A Serpick
Cancer Chemotherapy Reports|October 1, 1970
An evaluation of large intermittent intravenous doses of cyclophosphamide (NSC-26271) in the treatment of metastatic malignant melanomaJ A Gottlieb, D Mendelson, A A Serpick
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer|December 1, 1970
Leukemic infiltration of the prostate: a reversible form of urinary obstructionW E Mitch, A A Serpick
Cancer Research|August 1, 1970
Prolonged intravenous methotrexate therapy in the treatment of acute leukemia and solid tumorsJ A Gottlieb, A A Serpick
Oncology|January 1, 1971
Clinical evaluation of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in malignant melanoma and other neoplasms: comparison of twice-weekly and daily administration schedulesJ A Gottlieb, A A Serpick
Blood|March 1, 1970
Granulocytic sarcoma (chloroma)P H Wiernik, A A Serpick
Cancer Chemotherapy Reports|October 1, 1970
An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lungJ A Gottlieb, A A Serpick
Cancer|March 1, 1970
Effect of large intermittent intravenous doses of cyclophosphamide in lymphomaD Mendelson, J B Block, A A Serpick
Cancer|May 1, 1970
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcomaS Lowenbraun, V T DeVita, A A Serpick
The American Journal of Medicine|January 1, 1971
Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapyS Lowenbraun, H E Ramsey, A A Serpick
Blood|December 1, 1970
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's diseaseS Lowenbraun, V T DeVita, A A Serpick
Cancer Chemotherapy Reports|October 1, 1970
An evaluation of large intermittent intravenous doses of cyclophosphamide (NSC-26271) in the treatment of metastatic malignant melanomaJ A Gottlieb, D Mendelson, A A Serpick
Pageof 4